Zobuxa 150 mg tablets for dogs
Zobuxa 150 mg tablets for dogs
Not authorised
- Enrofloxacin
Product identification
Medicine name:
Zobuxa 150 mg tablets for dogs
Zobuxa 150 mg Tabletten für Hunde
Active substance:
- Enrofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
Package description:
- (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet
- (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-01009
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0197/004
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 15/02/2022
German (PDF)
Published on: 4/03/2019
Updated on: 18/12/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 4/03/2019
Updated on: 18/12/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 4/03/2019
Updated on: 18/12/2024
How useful was this page?:
